Skip to main content
Mabion S.A. logo

Mabion S.A. — Investor Relations & Filings

Ticker · MAB ISIN · PLMBION00016 LEI · 259400KG5JVQPPZL6X53 WAR Manufacturing
Open in API
Filings indexed 1,002 across all filing types
Latest filing 2022-06-21 Declaration of Voting R…
Country PL Poland
Listing WAR MAB

About Mabion S.A.

https://www.mabion.eu/en/

Mabion S.A. is an integrated Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for the development and manufacturing of protein-based biotherapeutics. The company specializes in monoclonal antibodies and biosimilars, offering a complete workflow from cell line development and banking to process optimization and large-scale GMP manufacturing. Core competencies include upstream processing using mammalian cell cultures, downstream purification involving chromatography and viral clearance, and technology transfer for scale-up. Mabion partners with pharmaceutical and biotechnology companies to support both clinical and commercial supply, streamlining the path from gene to final drug product.

Recent filings

Filing Released Lang Actions
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zgromadzeniu Spółki w dniu 21 czerwca 2022 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text is very short (271 characters) and explicitly states that the management of Mabion S.A. is providing an attachment ('przekazuje w załączeniu') containing a list of shareholders who held at least 5% of the votes at the Annual General Meeting (Zwyczajnym Walnym Zgromadzeniu Spółki) held on June 21, 2022. This structure—a brief announcement stating that the actual information is attached or enclosed—strongly suggests a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), rather than the full report itself. Since the content relates to voting results from a general meeting, it is closely related to DVA (Declaration of Voting Results), but the *format* is an announcement of publication. Given the options, RPA (Report Publication Announcement) fits the 'MENU VS MEAL' rule best, as it is announcing the publication of specific data related to the AGM. If the content were the full list, DVA would be appropriate, but as a brief notice of enclosure, RPA is the classification.
2022-06-21 Polish
Załącznik do Uchwały ZWZ nr 26/VI/2022
AGM Information Classification · 98% confidence The document text is titled "REGULAMIN WALNEGO ZGROMADZENIA MABION SPÓŁKI AKCYJNEJ" (Rules of the General Meeting of Mabion S.A.) and details the procedures for convening, organizing, conducting, and documenting the General Meeting (Walne Zgromadzenie). It specifically references resolutions from the Annual General Meeting (Zwyczajne Walne Zgromadzenie Akcjonariuszy) and outlines rules for participation, voting, and the role of the Chairman and Scrutiny Committee. This content directly relates to the formal proceedings and materials associated with the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2022-06-21 Polish
Uchwały Zwyczajnego Walnego Zgromadzenia z dnia 21 czerwca 2022 r.
AGM Information Classification · 99% confidence The document text is titled 'TREŚĆ UCHWAŁ ZWYCZAJNEGO WALNEGO ZGROMADZENIA MABION S.A. Z DNIA 21 CZERWCA 2022 ROKU' (Content of Resolutions of the Ordinary General Meeting of Mabion S.A. of June 21, 2022). It consists entirely of numbered resolutions passed during this meeting, covering topics like approving the agenda, approving the 2021 annual report and financial statements, approving the distribution of profit, and crucially, granting 'absolutorium' (discharge/approval) to members of the Management Board and Supervisory Board for the 2021 fiscal year. The presence of resolutions regarding the discharge of management (absolutorium) and the review of annual reports strongly indicates this document relates to the proceedings of the Annual General Meeting (AGM). While it touches upon annual report items, the primary nature is the record of decisions made at the meeting itself. Therefore, the most appropriate classification is AGM Information (AGM-R).
2022-06-21 Polish
Treść uchwał Zwyczajnego Walnego Zgromadzenia Mabion S.A. z dnia 21 czerwca 2022 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document text is very short (477 characters) and explicitly states that the management ('Zarząd Mabion S.A.') is enclosing ('przekazuje w załączeniu') the content of resolutions ('treść uchwał') voted upon at the Annual General Meeting ('Zwyczajnym Walnym Zgromadzeniu Spółki') held on June 21, 2022. This content relates directly to the results of shareholder voting at a general meeting. The most specific category for official results from shareholder votes is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it contains the results, the structure suggests it is the official announcement/filing of those results, rather than the full AGM presentation (AGM-R) or a proxy statement (PSI). Given the content focuses entirely on the resolutions and voting outcomes, DVA is the best fit.
2022-06-21 Polish
Rozszerzenie zakresu współpracy z Novavax - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement in Polish (Raport bieżący) referencing previous reports and detailing a specific contractual expansion (SOW#5) with Novavax regarding stability testing for vaccine components. This concerns a significant business development, specifically related to production contracts and ongoing operational agreements, rather than a standard financial report (like 10-K or IR), a management change (MANG), or a dividend announcement (DIV). It describes a material event impacting the company's operations and agreements. Since it is a report detailing a specific business transaction/agreement update, and not a general regulatory filing fallback (RNS) or a report announcement (RPA), it best fits under a category related to significant corporate actions or material information disclosure. Given the options, this type of specific contractual/operational update that is not explicitly covered by other categories (like M&A, Financing, or Earnings) often falls under general Regulatory Filings (RNS) if it's a mandatory disclosure that doesn't fit a more specific SEC/exchange form type, or potentially a general business update. However, since it details a specific, material business agreement expansion, and is not a standard financial report, RNS is the most appropriate fallback for a non-US specific regulatory disclosure of this nature, as it is a 'current report' (Raport bieżący) about a material event.
2022-06-08 Polish
Rozszerzenie zakresu usług umowy produkcyjnej z Novavax - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement in Polish, referencing previous current reports ('raport bieżący') regarding a manufacturing agreement ('Umowa produkcyjna') with Novavax. It details the signing of an extension, 'Specyfikacja Warunków Zlecenia #4' (SOW#4), which expands the scope of services to include quality testing and analytical method transfer for Novavax's final product (vaccine). This constitutes a significant business development, specifically related to a contract or transaction involving the company's operations and potential revenue streams, but it is not a standard financial report (10-K, IR, ER) or a management/board change announcement. It is a material event disclosure. Given the options, this type of significant business/contractual update that doesn't fit perfectly into financing (CAP) or M&A (TAR) is best categorized as a general Regulatory Filing (RNS), as it is a required disclosure of a material event.
2022-05-30 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.